Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jewell

Showing results (31-40 of 621) with videos related to

Pageof 63
Sort By:
Statistics in Medicine|January 1, 1991
A comparison of maximum likelihood and Jewell's estimator of the odds ratio and relative risk in single 2 x 2 tablesN P Jewell
American Journal of Ophthalmology|November 3, 2009
Risk interpretation, perception, and communicationNicholas P Jewell
American Journal of Ophthalmology|September 29, 2009
Risk comparisonsNicholas P Jewell
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 1, 1989
[New treatments for ulcerative colitis and Crohn's disease]D P Jewell
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2002
Infliximab for ulcerative colitisJ Simmons, D P Jewell
Clinical Science (London, England : 1979)|February 1, 1990
Mechanism of action of 5-aminosalicylic acid and its derivativesA Ireland, D P Jewell
Expert Review of Gastroenterology & Hepatology|March 2, 2012
The IL-23/IL-17 pathway in inflammatory bowel diseaseAlessandra Geremia, Derek P Jewell
European Journal of Gastroenterology & Hepatology|February 1, 1996
Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease?J Satsangi, D P Jewell
The Italian Journal of Gastroenterology|June 1, 1994
Response to treatment of microscopic colitisR Fasoli, D P Jewell
Scandinavian Journal of Gastroenterology|April 1, 1991
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac diseaseG Mantzaris, D P Jewell
Pageof 63

Showing results (31-40 of 621) with videos related to

Sort By:
Pageof 63
Statistics in Medicine|January 1, 1991
A comparison of maximum likelihood and Jewell's estimator of the odds ratio and relative risk in single 2 x 2 tablesN P Jewell
American Journal of Ophthalmology|November 3, 2009
Risk interpretation, perception, and communicationNicholas P Jewell
American Journal of Ophthalmology|September 29, 2009
Risk comparisonsNicholas P Jewell
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 1, 1989
[New treatments for ulcerative colitis and Crohn's disease]D P Jewell
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2002
Infliximab for ulcerative colitisJ Simmons, D P Jewell
Clinical Science (London, England : 1979)|February 1, 1990
Mechanism of action of 5-aminosalicylic acid and its derivativesA Ireland, D P Jewell
Expert Review of Gastroenterology & Hepatology|March 2, 2012
The IL-23/IL-17 pathway in inflammatory bowel diseaseAlessandra Geremia, Derek P Jewell
European Journal of Gastroenterology & Hepatology|February 1, 1996
Are cytokine gene polymorphisms important in the pathogenesis of inflammatory bowel disease?J Satsangi, D P Jewell
The Italian Journal of Gastroenterology|June 1, 1994
Response to treatment of microscopic colitisR Fasoli, D P Jewell
Scandinavian Journal of Gastroenterology|April 1, 1991
In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac diseaseG Mantzaris, D P Jewell
Pageof 63